Ejiofor Chika Achalu, MD | |
2152 Old Springville Rd, Center Point, AL 35215-4005 | |
(205) 838-6000 | |
(205) 838-6078 |
Full Name | Ejiofor Chika Achalu |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2152 Old Springville Rd, Center Point, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215509054 | NPI | - | NPPES |
P110445 | Other | NY | PHYSICIAN LIMITED PERMIT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | P110445 (New York) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ejiofor Chika Achalu, MD 71 Jonathan Rd, Pelham, NH 03076-2174 Ph: (978) 483-1240 | Ejiofor Chika Achalu, MD 2152 Old Springville Rd, Center Point, AL 35215-4005 Ph: (205) 838-6000 |
News Archive
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications
Today, the Mental Health Now, or mhNOW, initiative will launch at the inaugural Financing and Innovation in Global Health (FIGH) conference. Led by mental health experts Chris Underhill, founder and president of BasicNeeds, and Moitreyee Sinha, head of health at the Global Development Incubator (GDI), mhNOW is a global, collective action including social entrepreneurs, organizations and companies that are working together to innovate and identify mental health solutions on a global scale, and systemically implement in communities at a local level.
W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GOREĀ® VIABAHNĀ® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.
A paper recently uploaded to the preprint server bioRxiv by researchers at Chapman University in California (Feb 22nd, 2021) utilized computational methods to screen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants for affinity with the angiotensin-converting enzyme 2 (ACE2) receptor and monoclonal antibodies REG10987 and REG10933.
In a recent survey among eyecare providers, nearly 30 percent hear the following question at least once a week: Will eating carrots really improve my vision?
› Verified 6 days ago